Nutrien is the world's largest producer of potash and a major supplier of nitrogen and phosphate fertilizers, sold through its own retail network of farm supply stores in North America, Brazil and Australia. Its structural advantage is scale in potash, a mineral with a concentrated supply base, plus a retail arm that gives it direct access to growers and a way to capture margin beyond the commodity itself. Growth is modest, with revenue up 4.0%, so the case rests more on earnings power through the fertilizer cycle than on top-line expansion. At 13.8 times trailing earnings and 13.5 times forward, the stock is priced without a heroic recovery assumption, and a 17.5% operating margin and 32.1% gross margin show the business still earns solid returns on its assets. The score of 58 out of 100 and a 9.4% return on equity say this is a cyclical name that needs a view on fertilizer prices and farm income before it earns a position, which is reason enough to open the model and check the potash price deck.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 19 Oct 2026, 19:04 CEST | Rating | Fairly valued | first publication | $71.26 |
| 19 Oct 2026, 19:04 CEST | Fair value | $73.85 | $89.73 | $71.26 |
| 15 Oct 2026, 00:00 CEST | Fair value | $89.73 | $93.75 | $69.68 |
| 11 Oct 2026, 00:00 CEST | Fair value | $93.75 | $87.61 | $67.48 |
| 5 Oct 2026, 00:00 CEST | Fair value | $87.61 | $88.66 | $70.06 |
| 28 Sept 2026, 00:00 CEST | Fair value | $88.66 | $90.24 | $72.23 |
| 26 Sept 2026, 00:00 CEST | Fair value | $90.24 | $91.26 | $73.96 |
| 21 Sept 2026, 00:00 CEST | ACCE price target | $78.00 | first publication | $77.09 |
| 14 Sept 2026, 00:00 CEST | Fair value | $91.26 | $93.97 | $78.45 |
| 26 Aug 2026, 00:00 CEST | Fair value | $93.97 | $95.19 | $73.80 |
Answered from Nutrien Ltd. Common Shares fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| NTR Nutrien Ltd. Common Shares | $69.74 | $74 | 6% below | 14.1x | 9.4% | 63 | 60 |
| NTR.TO Nutrien | C$96.70 | C$104 | 7% below | 14.3x | 9.4% | 63 | 60 |
| CF CF Industries Holdings Inc. Common Stock | $118.56 | $142 | 17% below | 8.6x | 29.9% | 87 | 85 |
| YAR.OL Yara International | kr 399.40 | kr 564 | 29% below | 7.5x | 17.9% | 64 | 66 |
| CTVA Corteva Inc. Common Stock | $12.86 | $27 | 52% below | 7.7x | 4.3% | 55 | 38 |
| ICL ICL Group Ltd. Ordinary Shares | $4.71 | $6 | 25% below | 19.9x | 5.6% | 56 | 56 |
| MOS Mosaic Company (The) Common Stock | $17.27 | $34 | 49% below | - | -5.1% | 27 | 34 |
Where NTR ranks against its sector peers on each metric.